Ticker

No recent analyst price targets found for BRTX.

Latest News for BRTX

Biorestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update

Biorestorative Therapies, Inc. (NASDAQ: BRTX - Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 11,586 shares, a decrease of 69.2% from the August 31st total of 37,641 shares. Currently, 1.0% of the company's stock are short sold.

Defense World • Sep 28, 2026
BioRestorative Therapies Announces Reverse Stock Split

MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (Nasdaq: BRTX) (“BioRestorative” or the “Company”), a late-stage clinical regenerative medicine company, today announced that the Company's Board of Directors approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company's common stock (the “Common Stock”). The Company was not required to obtain stockholder…

GlobeNewsWire • Sep 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for BRTX.

No House trades found for BRTX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top